Yeshwant Krishna (CIK 1585001) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-28). Recent activity: Sell VERV (6.1M shares), Sell VERV (4.3M shares), Sell VERV (1.8M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) | Director | Sell | 6.1M | $0 |
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) | Director | Sell | 4.3M | $0 |
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) | Director | Sell | 1.8M | $0 |
Source: SEC Form 4 filings · as of 2025-07-28